Comparations of efficacy and safety of rituximab, calcineurin inhibitors and cyclophosphamide in primary membranous nephropathy: a single-center retrospective analysis
2024 · BMC Nephrology · 7 citations
https://doi.org/10.1186/s12882-024-03912-4
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
9
Papers
123
Citations
4
h-index
2
i10-index
Shasha Cai is an academic researcher from Huaian First People’s Hospital. The author has contributed to research in topics: Chronic Kidney Disease and Diabetes & RNA Research and Splicing & Renal Diseases and Glomerulopathies. The author has an h-index of 4, co-authored 8 publications.
ORCID: 0000-0002-3297-4702Click to start Chat